CG
APLT

Cutler Group’s Applied Therapeutics APLT Stock Holding History

Cutler Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4K Buy
+700
New +$3.14K ﹤0.01% 1605
2022
Q2 		– Sell
-220
Closed – – 4925
2022
Q1 		$0 Buy
+220
New +$589 ﹤0.01% 5263

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Cutler Group's APLT Position: Q1 2024 in Review

Cutler Group opened a new position in Applied Therapeutics (APLT) in Q1 2024: 700 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #1605 among its holdings. This is a return to the name: Cutler Group previously reported a position in APLT as recently as Q1 2022.

Cutler Group first reported a position in APLT in Q1 2022 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold APLT as of Q1 2024.

  • Cutler Group held 700 shares of Applied Therapeutics worth $4K as of Q1 2024.
  • Applied Therapeutics was a new Cutler Group position in Q1 2024.
  • Applied Therapeutics made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1605 holding.
  • Cutler Group first reported a position in Applied Therapeutics in Q1 2022 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.